Migraine and epilepsy: A focus on overlapping clinical, pathophysiological, molecular, and therapeutic aspects

Current Pain and Headache Reports

Volumn 14, Issue 4, 2010, Pages 276-283

  Bianchin, Marino Muxfeldt ^a   Londero, Renata Gomes ^b   Lima, José Eduardo ^c   Bigal, Marcelo Eduardo ^d,e  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^d MERCK RESEARCH LABORATORIES   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Comorbidity; Epilepsy; Headache; Migraine; Paroxysmal disorders

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA2 SUBUNIT; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C10 PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CELL PROTEIN; DNA DIRECTED DNA POLYMERASE GAMMA; ETIRACETAM; EXCITATORY AMINO ACID TRANSPORTER 1; GABAPENTIN; NEUROLEPTIC AGENT; PLACEBO; SODIUM CHANNEL NAV1.1; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VOLTAGE DEPENDENT P TYPE CALCIUM CHANNEL ALPHA1A SUBUNIT; VOLTAGE DEPENDENT Q TYPE CALCIUM CHANNEL ALPHA1A SUBUNIT; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL ALPHA1 SUBUNIT; ZONISAMIDE;

BEDTIME DOSAGE; BENIGN CHILDHOOD EPILEPSY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONVULSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE PHENOTYPE CORRELATION; HEADACHE; HUMAN; HYPERTENSION; MIGRAINE; MOLECULAR DYNAMICS; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; REVIEW; RISK FACTOR; ROLANDIC EPILEPSY; SEIZURE THRESHOLD; SEX DIFFERENCE; SIDE EFFECT; SPREADING CORTICAL DEPRESSION; SYNDROME DELINEATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT GAIN; WEIGHT REDUCTION;

ANALGESICS; ANIMALS; ANTICONVULSANTS; EPILEPSY; HUMANS; MIGRAINE DISORDERS; MUTATION;

EID: 77956383573     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0121-y     Document Type: Review

References (65)

1. Stovner LJ, Hagen K, Jensen R, et al.: The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193-210. This article is a comprehensive review about the global impact of headache disorders according to headache type.
2. Lipton RB, Bigal ME: Migraine: Epidemiology, impact, and risk factors for progression. Headache 2005, 45(Suppl 1):S3-S13.
3. Sander JW, Shorvon SD: Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996, 61:433-443.
4. Published erratum appears in J Neurol Neurosurg Psychiatry 1997, 62:679.
5. de Boer HM, Mula M, Sander JW: The global burden and stigma of epilepsy. Epilepsy Behav 2008, 12:540-546.
6. Pace BP, Sullivan-Fowler M: JAMA 100 years ago: A slander on the medical profession. JAMA 1996, 276:1222b.
7. Haut SR, Bigal ME, Lipton RB: Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol 2006, 5:148-157. This excellent review examines similarities and contrasts between migraine and epilepsy.
8. Andermann F, Andermann E: Migraine and epilepsy, with special reference to the benign epilepsies of childhood. Epilepsy Res Suppl 1992, 6:207-214.
9. Ottman R, Lipton RB: Comorbidity of migraine and epilepsy. Neurology 1994, 44:2105-2110.
10. Ottman R, Lipton RB: Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology 1996, 47:918-924.
11. Di Clemente L, Coppola G, Magis D, et al.: Interictal habituation deficit of the nociceptive blink reflex: An endophenotypic marker for presymptomatic migraine? Brain 2007, 130:765-770.
12. Leniger T, von den Driesch S, Isbruch K, et al.: Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 2003, 43:672-677.
13. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24 (Suppl 1):9-160.
14. Bernasconi A, Andermann F, Bernasconi N, et al.: Lateralizing value of peri-ictal headache: A study of 100 patients with partial epilepsy. Neurology 2001, 56:130-132.
15. Yankovsky AE, Andermann F, Bernasconi A: Characteristics of headache associated with intractable partial epilepsy. Epilepsia 2005, 46:1241-1245.
16. Cai S, Hamiwka LD, Wirrell EC: Peri-ictal headache in children: Prevalence and character. Pediatr Neurol 2008, 39:91-96.
17. Yankovsky AE, Andermann F, Mercho S, et al.: Preictal headache in partial epilepsy. Neurology 2005, 65:1979-1981.
18. Laplante P, Saint-Hilaire JM, Bouvier G: Headache as an epileptic manifestation. Neurology 1983, 33:1493-1495.
19. Moskowitz MA: Genes, proteases, cortical spreading depression and migraine: Impact on pathophysiology and treatment. Funct Neurol 2007, 22:133-136.
20. Marks DA, Ehrenberg BL: Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 1993, 43:2476-2483.
21. Leniger T, Isbruch K, von den Driesch S, et al.: Seizure-associated headache in epilepsy. Epilepsia 2001, 42:1176-1179.
22. Piccioli M, Parisi P, Tisei P, et al.: Ictal headache and visual sensitivity. Cephalalgia 2009, 29:194-203.
23. Isler H, Wirsen ML, Elli N: Hemicrania epileptica: Synchronous ipsilateral ictal headache with migraine features. In Migraine and Epilepsy. Edited by Andermann F, Lugaresi E. Boston: Butterworths; 1987:246-263.
24. Guerrini R, Genton P: Epileptic syndromes and visually induced seizures. Epilepsia 2004, 45(Suppl 1):14-18.
25. Ito M, Adachi N, Nakamura F, et al.: Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia 2004, 24:23-28.
26. Ogunyemi A, Adams D: Migraine-like symptoms triggered by occipital lobe seizures: Response to sumatriptan. Can J Neurol Sci 1998, 25:151-153.
27. Caraballo RH, Cersósimo RO, Fejerman N: Childhood occipital epilepsy of Gastaut: A study of 33 patients. Epilepsia 2008, 49:288-297.
28. Taylor I, Berkovic SF, Kivity S, Scheffer IE: Benign occipital epilepsies of childhood: Clinical features and genetics. Brain 2008, 131:2287-2294. The authors examine early and late benign occipital epilepsies of childhood as two discrete electroclinical syndromes, exploring clinical features and clinical genetics of these two syndromes.
29. Panayiotopoulos CP, Michael M, Sanders S, et al.: Benign childhood focal epilepsies: Assessment of established and newly recognized syndromes. Brain 2008, 131:2264-2286.
30. Caraballo R, Koutroumanidis M, Panayiotopoulos CP, Fejerman N: Idiopathic childhood occipital epilepsy of Gastaut: A review and differentiation from migraine and other epilepsies. J Child Neurol 2009, 24:1536-1542.
31. Wirrell EC, Hamiwka LD: Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia 2006, 47:1674-1681.
32. Clarke T, Baskurt Z, Strug LJ, Pal DK: Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 2009, 50:2428-2433.
33. Deprez L, Peeters K, Van Paesschen W, et al.: Familial occipitotemporal lobe epilepsy and migraine with visual aura: Linkage to chromosome 9q. Neurology 2007, 68:1995-2002.
34. Deprez L, Weckhuysen S, Peeters K, et al.: Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia 2008, 49:500-508.
35. Barrett CF, van den Maagdenberg AM, Frants RR, Ferrari MD: Familial hemiplegic migraine. Adv Genet 2008, 63:57-83. The authors review clinical features of migraine and discuss the continuing highway of migraine gene discovery.
36. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001, 41:646-657.
37. Engel J Jr; International League Against Epilepsy (ILAE): A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
38. Crompton DE, Berkovic SF: The borderland of epilepsy: Clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol 2009, 8:370-381. The authors present an interesting discussion about clinical and molecular similarities and differences of epileptic seizures from other paroxysmal disorders.
39. Wild E: Deja vu in neurology. J Neurol 2005, 252:1-7.
40. Gaitatzis A, Sander JW: The mortality of epilepsy revisited. Epileptic Disord 2004, 6:3-13.
41. Goadsby PJ, Hoskin KL: Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine? Pain 1996, 67:355-359.
42. Hargreaves R: New migraine and pain research. Headache 2007, 47(Suppl 1):S26-S43.
43. de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM: Molecular genetics of migraine. Hum Genet 2009, 126:115-132. This is an excellent and comprehensive review about molecular aspects of migraine.
44. Bahra A, Matharu MS, Buchel C, et al.: Brainstem activation specific to migraine headache. Lancet 2001, 357:1016-1017.
45. Goadsby PJ: Neurovascular headache and a midbrain vascular malformation: Evidence for a role of the brainstem in chronic migraine. Cephalalgia 2002, 22:107-111.
46. Lauritzen M: Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994, 117:199-210.
47. Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
48. Ayata C, Jin H, Kudo C, et al.: Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006, 59:652-661.
49. Aurora SK: Is chronic migraine one end of a spectrum of migraine or a separate entity? Cephalalgia 2009, 29:597-605.
50. Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
51. Tottene A, Conti R, Fabbro A, et al.: Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 2009, 61:762-773.
52. Gargus JJ: Genetic calcium signaling abnormalities in the central nervous system: Seizures, migraine, and autism. Ann N Y Acad Sci 2009, 1151:133-156.
53. De Fusco M, Marconi R, Silvestri L, et al.: Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003, 33:192-196.
54. Castro MJ, Stam AH, Lemos C, et al.: Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine. J Hum Genet 2007, 52:990-998.
55. Dichgans M, Freilinger T, Eckstein G, et al.: Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371-377.
56. Gambardella A, Marini C: Clinical spectrum of SCN1A mutations. Epilepsia 2009, 50(Suppl 5):20-23.
57. Fujiwara T: Clinical spectrum of mutations in SCN1A gene: Severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res 2006, 70(Suppl 1):S223-S230.
58. Harkin LA, McMahon JM, Iona X, et al.: The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007, 130:843-852. The authors present an expanded spectrum of epileptic encephalopathies associated with SCN1A mutations.
59. Claes LR, Deprez L, Suls A, et al.: The SCN1A variant database: A novel research and diagnostic tool. Hum Mutat 2009, 30:E904-E920.
60. Jen JC, Wan J, Palos TP, et al.: Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005, 65:529-534.
61. Tzoulis C, Engelsen BA, Telstad W, et al.: The spectrum of clinical disease caused by the A467T and W748S POLG mutations: A study of 26 cases. Brain 2006, 129:1685-1692.
62. Lönnqvist T, Paetau A, Valanne L, Pihko H: Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009, 132:1553-1562.
63. Silberstein SD: Clinical practice guidelines. Cephalalgia 2005, 25:765-766.
64. Silberstein SD: Topiramate in migraine prevention: Evidencebased medicine from clinical trials. Neurol Sci 2004, 25(Suppl 3): S244-S245.
65. Rapoport AM, Bigal ME: Migraine preventive therapy: Current and emerging treatment options. Neurol Sci 2005, 26(Suppl 2): S111-s120.